Antiparkinsonian drugs: pharmacological and therapeutic aspects

The cardiovascular effects of bromocriptine in Parkinsonism.

British journal of clinical pharmacology·2012

German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia - Longitudinal observations.

Parkinsonism & related disorders·2008

The role of the Lewy body in idiopathic Parkinsonism.

Parkinsonism & related disorders·2008

The natural history of neurological manganism over 18 years.

Parkinsonism & related disorders·2006

Autosomal dominant dystonia-plus with cerebral calcifications.

Neurology·2006

Genetic heterogeneity in familial idiopathic basal ganglia calcification (Fahr disease).

Neurology·2004

Antibiotic-Refractory Chronic Pouchitis After Ileal Pouch-Anal Anastomosis: Current and Emerging Therapeutic Strategies.

Drugs·2026

Current and Emerging Biomarkers and Surrogate Endpoints in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Drugs·2026

Doravirine/Islatravir: First Approval.

Drugs·2026

Anbenitamab: First Approval.

Drugs·2026

GLP-1 Receptor Agonists and Musculoskeletal Outcomes: A Systematic Literature Review and Meta-Analysis.

Drugs·2026

Safety Profile of the Non-steroidal Anti-inflammatory Drug Celecoxib in the Short-Term Management of Acute Non-cancer Pain: A Systematic Review with Meta-analysis of Randomised Controlled Trials.

Drugs·2026

Oral PCSK9 inhibitors: closing the gap between potency and practicality.

Current opinion in lipidology·2026

SGLT2 Inhibitors: Dual Effects on Erythropoiesis and Bone Metabolism.

Journal of bone metabolism·2026

Benzodiazepines in Epilepsy: A US Perspective on Clinical Use, Pharmacology, Abuse Methods, and Public Health Considerations.

Neurology and therapy·2026

Public funding for paediatric medications in Canada.

Paediatrics & child health·2026

Sarcolipin is a Conformation-Dependent Regulator of the Sarcoplasmic Reticulum Calcium Pump SERCA.

The Journal of membrane biology·2026

Scopolamine ameliorates psoriasis by blocking M1 receptor-mediated IL-23 production in dendritic cells.

Journal of immunology (Baltimore, Md. : 1950)·2026

Related Experiment Videos

Antiparkinsonian drugs: pharmacological and therapeutic aspects

Related Concept Videos

The cardiovascular effects of bromocriptine in Parkinsonism.

German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia - Longitudinal observations.

The role of the Lewy body in idiopathic Parkinsonism.

The natural history of neurological manganism over 18 years.

Autosomal dominant dystonia-plus with cerebral calcifications.

Genetic heterogeneity in familial idiopathic basal ganglia calcification (Fahr disease).

Antibiotic-Refractory Chronic Pouchitis After Ileal Pouch-Anal Anastomosis: Current and Emerging Therapeutic Strategies.

Current and Emerging Biomarkers and Surrogate Endpoints in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Doravirine/Islatravir: First Approval.

Anbenitamab: First Approval.

GLP-1 Receptor Agonists and Musculoskeletal Outcomes: A Systematic Literature Review and Meta-Analysis.

Safety Profile of the Non-steroidal Anti-inflammatory Drug Celecoxib in the Short-Term Management of Acute Non-cancer Pain: A Systematic Review with Meta-analysis of Randomised Controlled Trials.

Oral PCSK9 inhibitors: closing the gap between potency and practicality.

SGLT2 Inhibitors: Dual Effects on Erythropoiesis and Bone Metabolism.

Benzodiazepines in Epilepsy: A US Perspective on Clinical Use, Pharmacology, Abuse Methods, and Public Health Considerations.

Public funding for paediatric medications in Canada.

Sarcolipin is a Conformation-Dependent Regulator of the Sarcoplasmic Reticulum Calcium Pump SERCA.

Scopolamine ameliorates psoriasis by blocking M1 receptor-mediated IL-23 production in dendritic cells.

Related Experiment Videos

Antiparkinsonian drugs: pharmacological and therapeutic aspects

Related Concept Videos

Related Articles